Genetic Technologies Limited
GNTLF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $9,673 | $10,348 | $9,218 | $1,335 |
| % Growth | -6.5% | 12.3% | 590.6% | – |
| Cost of Goods Sold | $3,760 | $4,335 | $321 | $361 |
| Gross Profit | $3,904 | $6,013 | $6,474 | -$240 |
| % Margin | 40.4% | 58.1% | 70.2% | -18% |
| R&D Expenses | $753 | $1,281 | $706 | $1,166 |
| G&A Expenses | $10,217 | $9,012 | $2,181 | $4,158 |
| SG&A Expenses | $12,827 | $11,725 | $10,310 | $5,798 |
| Sales & Mktg Exp. | $2,609 | $2,712 | $1,885 | $436 |
| Other Operating Expenses | -$1,130 | -$927 | $0 | $0 |
| Operating Expenses | $12,450 | $12,079 | $11,016 | $6,964 |
| Operating Income | -$12,210 | -$6,066 | -$4,811 | -$5,799 |
| % Margin | -126.2% | -58.6% | -52.2% | -434.5% |
| Other Income/Exp. Net | $193 | -$5,843 | -$2,352 | -$1,278 |
| Pre-Tax Income | -$12,017 | -$11,909 | -$7,163 | -$7,078 |
| Tax Expense | $0 | -$158 | -$32 | $0 |
| Net Income | -$12,017 | -$11,751 | -$7,131 | -$7,078 |
| % Margin | -124.2% | -113.6% | -77.4% | -530.3% |
| EPS | -0.091 | -0.12 | -0.077 | -0.083 |
| % Growth | 24.3% | -55.2% | 6.6% | – |
| EPS Diluted | -0.091 | -0.12 | -0.077 | -0.083 |
| Weighted Avg Shares Out | 138,367 | 101,381 | 92,203 | 85,442 |
| Weighted Avg Shares Out Dil | 138,367 | 101,381 | 92,203 | 85,442 |
| Supplemental Information | – | – | – | – |
| Interest Income | $120 | $220 | $36 | $62 |
| Interest Expense | $52 | $30 | $15 | $14 |
| Depreciation & Amortization | $535 | $677 | $343 | $266 |
| EBITDA | -$11,431 | -$11,203 | -$7,201 | -$7,156 |
| % Margin | -118.2% | -108.3% | -78.1% | -536.1% |